The Food And Drug Administration (FDA) has extended the approval of Gilead’s Remdesivir (Veklury) for the treatment of COVID-19 in children aged 28 days and above. The FDA approved remdesivir for treating severe COVID-19 in adults in October 2020.
The Food And Drug Administration (FDA) has extended the approval of Gilead’s Remdesivir (Veklury) for the treatment of COVID-19 in children aged 28 days and above. The FDA approved remdesivir for treating severe COVID-19 in adults in October 2020.
Get updates delivered right to your inbox!
